Home » Topics » BioWorld Science

BioWorld Science
RSS

ProCyte launches Iamin gel in U.S.

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Exocell granted U.S. patent for A717

June 28, 1996

Sankyo to file NDA for Noscal

June 28, 1996

Nadolol/isosorbide monohydrate combination prevents rebleeding

June 28, 1996

SciClone's Zadaxin receives approval in Phillippines

June 28, 1996

PD-140548: Non-peptide cholecystokinin CCK-A antagonist

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.